| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |